Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000458962 | SCV000558887 | likely benign | Fanconi anemia | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001764459 | SCV001991003 | uncertain significance | not provided | 2019-05-29 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Genetic Services Laboratory, |
RCV001821345 | SCV002069408 | likely benign | not specified | 2021-04-06 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000458962 | SCV002534991 | uncertain significance | Fanconi anemia | 2021-11-15 | criteria provided, single submitter | curation | |
KCCC/NGS Laboratory, |
RCV001276506 | SCV004017588 | likely benign | Fanconi anemia complementation group A | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001764459 | SCV004218550 | uncertain significance | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | To the best of our knowledge, this variant has not been reported in the published literature. The frequency of this variant in the general population, 0.00052 (13/24958 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on FANCA mRNA splicing yielded predictions that this variant may result in the gain of a cryptic splice site without affecting the natural splice sites . Based on the available information, we are unable to determine the clinical significance of this variant. |
Prevention |
RCV003970325 | SCV004782733 | likely benign | FANCA-related disorder | 2023-06-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001276506 | SCV001462885 | likely benign | Fanconi anemia complementation group A | 2020-09-16 | no assertion criteria provided | clinical testing |